sinovac biotech ltd

Sinovac’s CoronaVac Trials Show Favorable Results

Early clinical trials show that Sinovac’s COVID-19 vaccine candidate safely induces an immune response in healthy volunteers within a month of vaccination.

Sinovac’s CoronaVac Shows Positive Early Results

Sinovac’s vaccine candidate for COVID-19 showed favorable immunogenicity and safety profiles in Phase I/II clinical trials.

Sinovac Receives Grant To Build HFMD Vaccine Plant

Vaccine manufacturer Sinovac has been awarded a US$9.6 million grant for the construction of a hand, foot and mouth disease vaccine facility.

Sinovac Seeks Approval For H7N9 Vaccine Clinical Trials

Sinovac Biotech has submitted a clinical trial application to commence clinical trials for its vaccine Avian influenza A (H7N9) vaccine.

Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate

Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.

Sinovac: Phase III Clinical Trial For Hand, Foot And Mouth Disease Vaccine

Chinese biopharmaceutical company Sinovac Biotech Ltd. has begun the Phase III clinical trial for its proprietary inactivated EV71 vaccine against hand, foot and mouth disease (HFMD).

Sinovac: PhII Clinical Trial For Hand, Food And Mouth Disease Vaccine

Sinovac Biotech Ltd. announced this week the commencement of a Phase II clinical trial for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease.